This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
BiomX’s acquisition of Adaptive Phage Therapeutics is looking like a good bet no...
Transcend Therapeutics has glided over the bar for success, linking its MDMA ana...
Opthea’s eye disease drug has failed its second phase 3 trial in a week, leaving...
Cologuard is getting an upgrade after 10 years on the market. Exact Sciences sai...
Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular dis...
Vertex is ending work on one of its two islet cell treatments after the diabetes...
The federal government is cutting 3,500 full-time FDA employees and 1,200 NIH wo...
Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at...
According to the FDA’s public database, since the start of this year the agency ...
Candel Therapeutics has identified a subpopulation of lung cancer patients livin...
Earlier this month, Ian Lipkin, M.D., and his team at Columbia University submit...
Visby's kit includes vaginal self-collection swabs and a palm-sized, PCR-based t...
CRISPR Therapeutics’ Julianne Bruno is hitting the exit in favor of external opp...
Relmada Therapeutics’ attempts to see whether a magic mushroom extract could be ...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
This week on "The Top Line," we hear from Nada Hanafi, co-founder of MedTech Col...
CRISPR Therapeutics’ Julianne Bruno is hitting the exit in favor of external opp...
BioNTech has shown why it made small cell lung cancer a priority for its PD-L1xV...
Lexicon Pharmaceuticals’ pursuit of the last word in obesity candidates has attr...
Having stripped back its workforce, antibiotics biotech Spero Therapeutics conti...
BioAtla is laying off 30% of staff as the biotech searches for partners for some...
As always, if you know of layoffs occurring at a biotech, please reach out to th...
The FDA has cleared a system designed to clean out the complex inner channels of...
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...